Literature DB >> 27059715

High prevalence of specific KIR types in patients with HHV-8 positive cutaneous vascular lesions: a possible predisposing factor?

Alessandro Borghi1, Maria D'Accolti2, Roberta Rizzo2, Annarosa Virgili1, Dario Di Luca2, Monica Corazza1, Elisabetta Caselli3.   

Abstract

Human herpesvirus 8 (HHV8) has been hypothesized to be a potential cofactor for the development of diverse cutaneous vascular proliferative lesions, including eruptive cherry angiomas. Recent reports evidenced the influence of killer cell immunoglobulin-like receptor (KIR) gene diversity in defining the susceptibility to symptomatic herpesvirus infections. In this study, skin samples from vascular lesions and healthy controls were characterized simultaneously for the presence of HHV8 and for the KIR genotype, focusing upon the presence of the KIR2DL2/DS2 and KIR2DL3 genes, which have been associated to herpesvirus susceptibility. The results showed that about 64 % of the vascular lesions resulted positive for the presence of HHV8, whereas no control healthy skin samples harbored HHV8 DNA. HHV8-positive patients had a significantly increased frequency of KIR2DL2/DS2 homozigosity and a concomitant decrease of the homozygous KIR2DL3 genotype, compared to healthy controls or HHV8-negative patients. Notably, the simultaneous presence of KIR2DL2/DS2 homozygosity and HHV8 infection resulted in a significantly increased risk to develop cutaneous lesions (OR 5.7) compared to the individual factors alone, suggesting that specific KIR genotypes might predispose to HHV8 symptomatic infection, allowing the virus to exert its angioproliferative activity at skin level.

Entities:  

Keywords:  Cherry angioma; HHV8; Killer cell immunoglobulin-like receptor (KIR); Skin angioproliferative lesions

Mesh:

Substances:

Year:  2016        PMID: 27059715     DOI: 10.1007/s00403-016-1643-x

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  5 in total

1.  Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma.

Authors:  Daria Bortolotti; Monica Corazza; Antonella Rotola; Dario Bencivelli; Giovanna Schiuma; Elisabetta Danese; Sabrina Rizzo; Silvia Beltrami; Roberta Rizzo; Alessandro Borghi
Journal:  Clin Exp Med       Date:  2022-02-15       Impact factor: 3.984

2.  Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture.

Authors:  Elisabetta Caselli; Chiara Fabbri; Maria D'Accolti; Irene Soffritti; Cristian Bassi; Sante Mazzacane; Maurizio Franchi
Journal:  BMC Microbiol       Date:  2020-05-18       Impact factor: 3.605

3.  HHV-6A Infection and Systemic Sclerosis: Clues of a Possible Association.

Authors:  Elisabetta Caselli; Irene Soffritti; Maria D'Accolti; Daria Bortolotti; Roberta Rizzo; Gianluca Sighinolfi; Dilia Giuggioli; Clodoveo Ferri
Journal:  Microorganisms       Date:  2019-12-24

4.  Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.

Authors:  Irene Soffritti; Maria D'Accolti; Chiara Fabbri; Angela Passaro; Roberto Manfredini; Giovanni Zuliani; Marco Libanore; Maurizio Franchi; Carlo Contini; Elisabetta Caselli
Journal:  Front Microbiol       Date:  2021-06-23       Impact factor: 5.640

Review 5.  The Interplay between Natural Killer Cells and Human Herpesvirus-6.

Authors:  Eva Eliassen; Dario Di Luca; Roberta Rizzo; Isabel Barao
Journal:  Viruses       Date:  2017-12-01       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.